Back
Amicus Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
FOLD
Amicus Therapeutics
Last Price:
9.68
Seasonality Move:
7.75%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Amicus Therapeutics Price Quote
$9.68
+0.02 (+1.89%)
(Updated: November 23, 2024 at 5:35 AM ET)
Amicus Therapeutics Key Stats
Sell
29
Amicus Therapeutics (FOLD)
is a Sell
Day range:
$9.46 - $9.78
52-week range:
$9.02 - $14.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.93
P/B ratio:
16.14%
Volume:
1.9M
Avg. volume:
2.7M
1-year change:
-9.21%
Market cap:
$2.9B
Revenue:
$399.4M
EPS:
$-0.34
How Much Does Amicus Therapeutics Make?
-
How Much Are Amicus Therapeutics's Sales Annually?
FOLD Revenues are $399.4M -
How Much Profit Does Amicus Therapeutics's Make A Year?
FOLD net income is -$151.6M
Is Amicus Therapeutics Growing As A Company?
-
What Is Amicus Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.37% -
What Is Amicus Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Amicus Therapeutics Stock Price Performance
-
Did Amicus Therapeutics Stock Go Up Last Month?
Amicus Therapeutics share price went down by -18.62% last month -
Did FOLD's Share Price Rise Over The Last Year?
FOLD share price fell by -9.21% over the past 1 year
What Is Amicus Therapeutics 52-Week High & Low?
-
What Is Amicus Therapeutics’s 52-Week High Share Price?
Amicus Therapeutics has traded as high as $14.57 over the past 52 weeks -
What Is Amicus Therapeutics’s 52-Week Low Share Price?
Amicus Therapeutics has traded as low as $9.02 over the past 52 weeks
Amicus Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Amicus Therapeutics?
-
How Much Debt Does Amicus Therapeutics Have?
Total long term debt quarterly is $389.5M -
How Much Cash Does Amicus Therapeutics Have?
Cash and short term investments quarterly total is $249.8M -
What Is Amicus Therapeutics’s Book Value Per Share?
Book value per share is 0.60
Is Amicus Therapeutics Cash Flow Positive?
-
What Is FOLD Cash Flow From Operations?
Cash flow from operations (TTM) is -$26.5M -
What Is Amicus Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.2M -
What Is Amicus Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.1M
Amicus Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FOLD return on invested capital is -19.5% -
What Is Amicus Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -13.78% -
What Is FOLD Return On Equity?
ROE is a measure of profitability and is -71.17%
Amicus Therapeutics Earnings Date & Stock Price
-
What Is Amicus Therapeutics's Stock Price Today?
A single share of FOLD can be purchased today for 9.66 -
What Is Amicus Therapeutics’s Stock Symbol?
Amicus Therapeutics trades on the nasdaq under the ticker symbol: FOLD -
When Is Amicus Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Amicus Therapeutics is scheduled on February 28, 2025 -
When Is FOLD's next ex-dividend date?
Amicus Therapeutics's next ex-dividend date is May 1, 2020 -
How To Buy Amicus Therapeutics Stock?
You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amicus Therapeutics Competitors
-
Who Are Amicus Therapeutics's Competitors?
Below is a list of companies who compete with Amicus Therapeutics or are related in some way:
Amicus Therapeutics Dividend Yield
-
What Is FOLD Dividend Yield?
Amicus Therapeutics’s dividend yield currently is 0% -
What Is Amicus Therapeutics’s Payout Ratio?
Amicus Therapeutics’s payout ratio is 0% -
When Did Amicus Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Amicus Therapeutics’s Dividend Per Share?
Amicus Therapeutics pays a dividend of $0.00 per share
Amicus Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 91.02% |
| Revenue: | 36.73% | 4.86% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 17.75 |
| Upside from Last Price: | 83.75% |